This precisely occurred with the surge and popularity of Ozempic, a GLP-1 FDA approved drug for diabetes but often prescribed for its off-label use of weight loss. The FDA received reports that ...

Regulators have approved the drug as a treatment for weight loss, Type 2 diabetes and lowering the risk of heart attacks and ...

GLP-1 medications are renowned for their ability to treat type 2 diabetes and aid weight loss. Now, there's a new benefit to ...

Is compounded semaglutide effective for weight loss? Here’s the short version: Compounded semaglutide isn’t approved by the ...

While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more ...

People who stayed on a 7.2 milligram weekly dose of semaglutide lost around 20% of their body weight over 72 weeks.

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Ozempic is more likely to be covered by insurance if it's prescribed for diabetes, not weight loss. The FDA has only approved Ozempic for those who have diabetes. For example, Medicare is not allowed ...

The increasing popularity of weight loss drugs like Wegovy®, Ozempic, Mounjaro and metformin may have you wondering how all ...

"Microdosing Ozempic or other [weight-loss] medications is entirely off ... in contrast to the FDA-approved versions that are simpler to use. Using the compounded versions through vials runs ...

Ozempic is primarily used for managing ... the same active ingredient found in Mounjaro. While Zepbound is FDA-approved for weight loss, Mounjaro is approved for managing type 2 diabetes.